A FACS analysis of typical cell cycle distribution observed in WT and p27KO control cells (vector) or H-Ras V12 -transformed fibroblasts, serum starved (T0) and then released in complete medium for the indicated times. B Western Blot analysis of Cyclin A (Cyc A), Cyclin B1 (Cyc B1), stathmin and p27 in WT and p27KO control (Vector) or H-Ras V12 -transformed fibroblasts, serum starved (0) and then released in complete medium (FBS) for the indicated times. Vinculin was used as loading control. C Graph reports the duplication time of WT and p27KO H-Ras V12 -transformed fibroblasts as evaluated in exponentially growing condition over a period of 4 days. Data report the mean of 2 ± SD of two different experiment performed with two different clones/genotype. Significance was calucluated using the Mann-Whitney unpaired test. D Matrigel evasion assay. Cells were included in a 3D-matrigel drop and incubated in complete medium for 48 hours. A typical image in phase contrast microscopy, using a 10X objective, is shown. Cells still included in the Matrigel drop (In) and cells already exited (Out) are indicated. E Transwell migration assay of WT and p27KO control cells (vector) or H-Ras V12 -transformed fibroblasts plated on transwell inserts coated with fibronectin and allowed to migrate up to six hours. Data represent the mean of 2 experiments performed in duplicate. F Wound healing migration assay of WT and p27KO control cells (vector) or corresponding H-Ras
V12
-transformed fibroblasts, grown to confluence on plastic dishes and then scratched and allowed to migrate into the wound up to 24 hours. Typical images in phase contrast microscopy, using a 10X objective, are shown.
Supplementary Figure S2. p27/stathmin interaction regulates H-Ras activity.
A Western Blot analysis of ERK1/2 activation in 3T3 WT, p27KO and DKO transformed with H-Ras V12 and in p27KO transformed fibroblasts re-expressing p27
WT or p27 1-170 (unable to bind stathmin) proteins. The expression of total ERK1/2, phosphorylated and total AKT, p27 and stathmin is also reported. B Soft agar assay of the indicated H-Ras V12 transformed fibroblasts, treated or not with FTI-276 inhibitor. Data represent the mean (+/-SD) of three different experiments in which colonies were counted in 8-10 fields/well for each condition. 
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Supplementary Materials and Methods
In vivo experiments
Primary tumors were established by subcutaneous injection of 1x10 
Cell cultures
Primary wild type (WT), p27 knock-out (p27KO) and p27/stathmin double KO (DKO) mouse embryo fibroblasts (MEF) were prepared from embryos at day 13.5, according to standard procedures. The correct genotype of WT, p27KO and p27/stathmin DKO cells was determined by PCR, as described [6, 7] . 3T3 fibroblasts were generated from primary MEFs, following the 3T3 immortalization protocol, as Clones and pools were selected in complete medium supplemented with 1.5 g/ml Puromycin and/or 0.4 mg/ml Hygromycin. The stable expression of the different constructs was tested by Western Blot analysis of the target protein. Each experiment has been performed using at least two independent clones or pools. To evaluate the anchorage-independent cell growth, H-Ras V12 and K-Ras Fresh medium with 1.5 μg/ml Puromycin and/or 0.4 mg/ml Hygromycin was added to the wells every 3 days. Where indicated, FTI inhibitor was added in the top agar and in the medium at the concentration of 6 μM. On day 15, the number of colonies was counted in 10 random fields at 10X magnification.
Generation of stable cell clones
Motility assays
For 3D-Matrigel™ evasion assay, cells (7,5x10 5 /ml) were included in Matrigel™ (6 mg/ml, Becton Dickinson) drops and maintained 1 hour upside-down at 37°C. Then, complete medium was added and cell motility monitored by transmission microscopy, using a Nikon TS100/F microscope and images collected using a CCD camera (Leica). The evasion ability was estimated by measuring the distance covered by the cells from the drop edges, 5 days after inclusion. To perform this analysis, cells were stained with crystal violet and pictures were taken. After conversion from pixel to millimeters, the actual distance covered was calculated. For the wound-healing assay, cells were grown to confluence in multiwell-plates and then scratched using a sterile tip. Pictures have been collected at different time points to evaluate the wound closure and the distance covered.
Tissue samples
A total of 17 sarcoma (leiomyosarcomas and fibromyosarcomas) and 37 breast tumor specimens were collected and diagnosed at Centro di Riferimento Oncologico (CRO) Proteins were extracted from frozen tissues, as described in Supplementary Materials.
RNA extraction, RT-PCR from tissue samples and quantitative Real-Time PCR
Isolation of RNA from cells, lung and circulating cells samples was performed using RNeasy-Mini Kit (QIAGEN), according to the manufacturer's instructions.
Disruption of the tissue sample was achieved by grinding the frozen tissue thoroughly with lead blocks. The homogenization was performed passing the lysate at least 5 times through a blunt 23-gauge needle fitted to an RNase-free syringe. This approach was used to identify circulating tumor cells and/or metastatic cells. We want to highlight that although we extracted the RNAs from tissues and from circulating cells pellets and we have probably lost any circulating free nucleic acid in our preparations we cannot completely exclude that our approach could have also led to the amplification of some residual circulating RNAs.
RNA were then quantified and retro-transcribed with AMV Reverse transcriptase, according to manufacturer's instructions (Promega) and the obtained cDNAs were amplified with nested PCR, in order to evaluate the presence of ectopic cells in tissue samples.
The following primers were used:
Samples were normalized by amplification of 18S ribosomal subunit. PCR products were then resolved on 1% agarose gels stained with ethidium bromide. Standard curves (10-fold dilution from 10 1 to 10 -4 attomoles) were prepared both for target genes and for housekeeping genes. The incorporation of the SYBR Green dye into the PCR products was monitored in real time using the Applied Biosystems ABI PRISM 7700 Sequence Detector, and the resulting threshold cycles (Ct) were computed. Ct values were converted into attomoles and the normalized target gene value was obtained by using at least two different housekeeping genes.
Preparation of protein lysates, immunoprecipitation and immunoblotting
Proteins were collected in indicated culture conditions, such as exponential growth, high confluence, starvation in serum free medium and after release in complete medium (10% FBS) or adhesion to Fibronectin (10 g/ml, Sigma). Where indicated, cells have been also treated with the following compounds for the indicated time:
FTI-276 (6 M, Sigma), Y27632 (10 M, Calbiochem), EGF (3 ng/ml, Invitrogen)..
To extract total proteins from cells, at the indicated time points, cells were scraped on ice using cold NP40 lysis buffer (0.5% NP40; 50 mM HEPES pH 7; 250 mM NaCl; 5 mM EDTA; 0.5 mM EGTA, pH 8), supplemented with a protease inhibitor cocktail (Complete™, Roche) and 1 mM Na 3 VO 4 (Sigma), 10 mM NaF (Sigma) and 1 mM DTT (Sigma). To extract total proteins from mouse organs or from tumor specimens, the same procedure was used, except that tissue disruption was first achieved by using the TissueLyser II (QIAGEN).
To perform the differential extraction of cytoplasmic and nuclear proteins, cells were resuspended in buffer A (10 mM HEPES pH 7.9, 0.1 mM EDTA pH 8, 0.1 mM EGTA pH 8, 10 mM KCl, 1 mM DTT), supplemented with the above listed inhibitors. Samples were incubated in ice for 15 minutes, then 0.5% NP40 was added and samples were centrifuged at max speed for 1 minute at 4°C. The supernatant, representing the cytoplasmic protein fraction, was collected. After 3 washes in 10%
NP40, pellets were digested in buffer C (20 mM HEPES pH 7.9, 1 mM EDTA pH 8, 1 mM EGTA pH 8, 400 mM NaCl, 1 mM DTT plus all the inhibitors) and incubated in ice for 20 minutes. Samples were then centrifuged at max speed for 15 minutes at 4°C, to recover the supernatant, representing the nuclear protein fraction.
For immunoblot analysis, proteins were separated in 4-20% SDS-PAGE (Criterion Precast Gel, Biorad) and transferred to nitrocellulose membranes (GE Healthcare).
Membranes were blocked with 5% dried milk in TBS-0.1% Tween20 or in Odyssey with expressing Ad-green adenoviruses encoding or not (control) for p27WT or p27CK-proteins, were lysed as described above and 2 mg of protein were incubated with glutathione S-transferase (GST)-Raf bound to glutathione-Sepharose high performance (GE Healthcare) for 1 h at 4°C. After thorough washes, the samples were boiled for 10 minutes in Laemmli buffer to detach active GTP-bound Ras, loaded on 15% SDS-PAGE gels (Criterion; Bio-Rad) and then immunoblotted using anti-FLAG antibody.
Immunofluorescence Analysis
For immunofluorescence analyses tumor specimens tissues embedded in OCT were sectioned with a cryostat and fixed with 4% PFA for 10 minutes at RT. After washing in PBS, sections were immersed into 10 mM citrate buffer pH 6. 
